{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:46:56Z","timestamp":1791092816049,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.vaccine.2006.06.046","type":"journal-article","created":{"date-parts":[[2006,11,4]],"date-time":"2006-11-04T12:14:12Z","timestamp":1162642452000},"page":"391-398","source":"Crossref","is-referenced-by-count":84,"title":["Modulation of the infant immune responses by the first pertussis vaccine administrations"],"prefix":"10.1016","volume":"25","author":[{"given":"F.","family":"Mascart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hainaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Peltier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Verscheure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Locht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.06.046_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0022-3476(87)80353-0","article-title":"Ontogeny of phytohemagglutinin-induced \u03b3 interferon by leukocytes of healthy infants and children: evidence for decreased production in infants younger than 2 months of age","volume":"111","author":"Frenkel","year":"1987","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2006.06.046_bib2","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.4049\/jimmunol.160.10.4730","article-title":"Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward Th2 cytokine profile","volume":"160","author":"Prescott","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.06.046_bib3","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1002\/1521-4141(200111)31:11<3394::AID-IMMU3394>3.0.CO;2-B","article-title":"High IL-13 production by human neonatal T cells: neonate immune system regulator?","volume":"31","author":"Ribeiro-do-Couto","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2006.06.046_bib4","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1128\/IAI.68.7.3873-3877.2000","article-title":"Antigen-specific responses to diphtheria-tetanus-acellular pertussis vaccine in human infants are initially Th2 polarized","volume":"68","author":"Rowe","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.06.046_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1086\/320996","article-title":"Heterogeneity in diphtheria-tetanus-acellular pertussis vaccine\u2014specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systemic Th1 function","volume":"184","author":"Rowe","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.06.046_bib6","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1365-2222.1992.tb00135.x","article-title":"Genetic \u201crisk\u201d for atopy is associated with delayed postnatal maturation of T-cell competence","volume":"22","author":"Holt","year":"1992","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.vaccine.2006.06.046_bib7","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1164\/ajrccm.161.supplement_2.a1q4-5","article-title":"Key factors in the development of asthma: atopy","volume":"161","author":"Holt","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2006.06.046_bib8","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1046\/j.1365-2222.2001.01176.x","article-title":"Selective development of a strong Th2 cytokine profile in high-risk children who develop atopy: risk factors and regulatory role of IFN-\u03b3, IL-4 and IL-10","volume":"31","author":"Van der Velden","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.vaccine.2006.06.046_bib9","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.4049\/jimmunol.170.3.1504","article-title":"Bordetella pertussis infection in 2-months-old infants promotes type 1 T cell responses","volume":"170","author":"Mascart","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.06.046_bib10","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1","article-title":"Neonatal bacillus Calmette-Gu\u00e9rin organism induces adult-like IFN-\u03b3 production by CD4+T lymphocytes","volume":"31","author":"Vekemans","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2006.06.046_bib11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMra020100","article-title":"The effect of infections on susceptibility to autoimmune and allergic diseases","volume":"347","author":"Bach","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2006.06.046_bib12","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4049\/jimmunol.168.2.919","article-title":"Influence of Mycobacterium bovis Bacillus Calmette-Gu\u00e9rin on antibody and cytokine responses to human neonatal vaccination","volume":"168","author":"Ota","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.06.046_bib13","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMcp041025","article-title":"Pertussis\u2014not just for kids","volume":"352","author":"Hewlett","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2006.06.046_bib14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1542\/peds.96.3.557","article-title":"Comparison of 13 acellular pertussis vaccines: adverse reactions","volume":"96","author":"Decker","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2006.06.046_bib15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJM199602083340609","article-title":"Acellular pertussis vaccines for infants","volume":"334","author":"Edwards","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2006.06.046_bib16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1286-4579(01)01421-6","article-title":"Immunity to Bordetella pertussis","volume":"3","author":"Mills","year":"2001","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2006.06.046_bib17","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1128\/IAI.65.6.2168-2174.1997","article-title":"Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccine","volume":"65","author":"Ausiello","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.06.046_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2567.1998.00401.x","article-title":"Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children","volume":"93","author":"Ryan","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2006.06.046_bib19","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.4049\/jimmunol.167.4.2411","article-title":"Down-regulation of IgE and IgG4 antibodies to tetanus toxoid and diphtheria toxoid by covaccination with cellular Bordetella pertussis vaccine","volume":"167","author":"Gruber","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.06.046_bib20","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/S0264-410X(00)00517-X","article-title":"Clinical relevance of lower Hib response in DTPa-based combination vaccines","volume":"19","author":"Poolman","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.06.046_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/01.inf.0000148929.91719.10","article-title":"Reduced immunogenicity of diphtheria and tetanus toxoids when combined with pertussis toxoid","volume":"24","author":"Trolfors","year":"2005","journal-title":"Pediat Infect Dis J"},{"key":"10.1016\/j.vaccine.2006.06.046_bib22","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.4049\/jimmunol.166.3.2141","article-title":"Deficient IL-12 (p35) gene expression by dendritic cells derived from neonatal monocytes","volume":"166","author":"Goriely","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.06.046_bib23","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S1286-4579(02)01601-5","article-title":"Whole-cell Bordetella pertussis vaccine component modulates the mouse immune response to an unrelated soluble antigen","volume":"4","author":"Lavigne","year":"2002","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2006.06.046_bib24","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/infdis\/146.2.290","article-title":"Elevation of levels of IgE antibody to tetanus toxo\u00efd in individuals vaccinated with diphtheria\u2013pertussis\u2013tetanus vaccine","volume":"146","author":"Matuhasi","year":"1982","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.06.046_bib25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0264-410X(94)00017-H","article-title":"Immunoglobulin E responses to diphtheria and tetanus toxo\u00efds after booster with aluminium-adsorbed and fluid DT-vaccines","volume":"13","author":"Mark","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.06.046_bib26","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s004310051264","article-title":"Local reactions and IgE antibodies to pertussis toxin after acellular diphtheria\u2013tetanus\u2013pertussis immunization","volume":"158","author":"Edelman","year":"1999","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2006.06.046_bib27","doi-asserted-by":"crossref","first-page":"8130","DOI":"10.1128\/IAI.73.12.8130-8135.2005","article-title":"Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children","volume":"73","author":"Rowe","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.06.046_bib28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nri1666","article-title":"Immune responses to tuberculosis in developing countries: implications for new vaccines","volume":"5","author":"Rook","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2006.06.046_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.275.5296.77","article-title":"Inverse association between tuberculin responses and atopic disorder","volume":"275","author":"Shirakawa","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2006.06.046_bib30","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1001\/archpedi.157.12.1184","article-title":"Allergic disease at the age of 7 years after pertussis vaccination in infancy: results from the follow-up of a randomized controlled trial of 3 vaccines","volume":"157","author":"Nilsson","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2006.06.046_bib31","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1016\/S0264-410X(03)00345-1","article-title":"Developmental factors associated with risk for atopic disease: implications for vaccine strategies in early childhood","volume":"21","author":"Holt","year":"2003","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06007742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06007742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T17:12:05Z","timestamp":1683652325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06007742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0264410X06007742"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.06.046","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}